Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Diaceutics PLC

Market Cap 121M 162M 140M 129M 226M 15.38B 230M 1.53B 593M 7.48B 607M 594M 25.92B P/E Ratio 2025 *
-
P/E Ratio 2026 * -
Enterprise Value 111M 149M 129M 119M 209M 14.18B 212M 1.41B 547M 6.9B 559M 548M 23.89B EV / Sales 2025
2.64x
EV / Sales 2026 * 2.4x
Free-Float
71.33%
Yield 2025 *
-
Yield 2026 * -
1 week+0.71%
Current month-0.35%
1 month-17.15%
3 months-3.06%
6 months+2.52%
Current year+11.33%
1 week 136
Extreme 136
144
1 month 136
Extreme 136
174
Current year 125
Extreme 125
180
1 year 112.25
Extreme 112.25
180
3 years 82
Extreme 82
180
5 years 74
Extreme 74
180
10 years 74
Extreme 74
195
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Date Insider Type Main position Quantity % Market Cap.
05-05Buy

Chief Financial Officer

90 0.0001%
05-05Free

Chief Financial Officer

90 0.0001%
05-05Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.71%+13.55%+65.70% 162M
+4.55%+2.00%+393.02%+1,126.82% 59.49B
+0.82%-7.40%+22.01%+38.25% 3.94B
-1.09%-14.85%+23.65%+92.12% 3.28B
+2.61%-4.29%-33.90%+17.10% 1.35B
+1.37%-2.72%-22.34%-56.74% 1.3B
0.00%-1.65%+27.13%+231.94% 1.22B
+4.48%+0.38%-29.21%+44.97% 1.13B
-0.83%-4.75%-32.18%-55.08% 1.07B
Average +1.32%-2.32%+40.19%+167.23% 8.11B
Weighted average by Cap. +3.84%+0.93%+321.27%+928.30%

Financials

2025 2026 *
Net sales 38.5M 51.62M 44.61M 41.13M 72.21M 4.91B 73.26M 487M 189M 2.39B 194M 190M 8.27B 47M 63.01M 54.45M 50.21M 88.15M 5.99B 89.44M 594M 231M 2.92B 236M 231M 10.1B
Net income -400K -536K -463K -427K -750K -51M -761K -5.06M -1.97M -24.81M -2.01M -1.97M -85.93M -1.1M -1.47M -1.27M -1.18M -2.06M -140M -2.09M -13.91M -5.41M -68.23M -5.53M -5.42M -236M
Net Debt -9.44M -12.65M -10.94M -10.08M -17.7M -1.2B -17.96M -119M -46.41M -585M -47.45M -46.48M -2.03B -7.71M -10.34M -8.93M -8.24M -14.46M -983M -14.67M -97.47M -37.91M -478M -38.76M -37.96M -1.66B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
12/06/26 142.50 p 0.00% 484,139
11/06/26 142.50 p 0.00% 126,613
10/06/26 142.50 p -0.35% 286,175
09/06/26 143.00 p 0.00% 201,399
08/06/26 143.00 p +1.06% 221,249
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.425GBP
Average target price
2.130GBP
Spread / Average Target
+49.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXRX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!